• The total number of prevalent cases of PDN across the countries under study will increase by 31% from 9.9 million in 2016 to 13 million in 2036.
  • We expect the age-specific proportions of PDN in the diabetic population to remain constant over the 20-year period based on the lack of evidence suggesting changes in risk factors associated with PDN.
  • %DD
  • %Rx

Table of contents

  • Painful Diabetic Neuropathy - Epidemiology - Mature Markets Data

Author(s): Sunali D. Goonesekera, SM; Wouter van der Pluijm, MPH

Sunali Goonesekera is an Associate Epidemiologist at Decision Resources Group.

Sunali holds a Master’s degree in Epidemiology from the Harvard School of Public Health and a B.A. in Biology (Honors) from Dartmouth College. Prior to joining Decision Resources Group, Sunali conducted epidemiological research and lead authored two manuscripts on racial/ethnic disparities in metabolic diseases at the New England Research Institutes. She has contributed to multiple publications in peer-reviewed journals in epidemiology and in the biological sciences.

Wouter van der Pluijm is a Senior Epidemiologist at Decision Resources Group and joined in 2014.

Wouter holds an M.P.H. in Epidemiology from the University of Michigan. Prior to joining DRG, Wouter worked for the Washtenaw County Public Health Department on the epidemiology and public health surveillance teams, studying West Nile virus, as well as depression and drug abuse in the county.